Document is current
Any future updates will be listed below
-
Authors
Thampi, P.
Seabaugh, K. A.
Pezzanite, L. M.
Chu, C. R.
Phillips, J. N.
Grieger, J. C.
McIlwraith, C. W.
Samulski, R. J.
Goodrich, L. R. https://orcid.org/0000-0002-8010-4429
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (62326995-156499, W81XWH1810572, W81XWH1810572, 62326995-156499, W81XWH1810572, 62326995-156499, W81XWH1810572, W81XWH1810572, W81XWH1810572, 62326995-156499, W81XWH1810572)
Asklepios BioPharmaceutical, Inc.
- License Information
-
More Information
Article History
Received: 20 March 2023
Revised: 26 June 2023
Accepted: 23 August 2023
First Online: 11 September 2023
Competing interests
: The authors declare no competing interests.
: All animal studies were approved and conducted in accordance with Institutional Animal Care and Use Committee (IACUC #1305) guidelines.
